Skip to main content
Top
Published in: Diabetologia 7/2017

Open Access 01-07-2017 | Article

Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study

Authors: Adam Hulman, Rebecca K. Simmons, Eric J. Brunner, Daniel R. Witte, Kristine Færch, Dorte Vistisen, Satoyo Ikehara, Mika Kivimaki, Adam G. Tabák

Published in: Diabetologia | Issue 7/2017

Login to get access

Abstract

Aims/hypothesis

South Asian individuals have reduced insulin sensitivity and increased risk of type 2 diabetes compared with white individuals. Temporal changes in glycaemic traits during middle age suggest that impaired insulin secretion is a particular feature of diabetes development among South Asians. We therefore aimed to examine ethnic differences in early changes in glucose metabolism prior to incident type 2 diabetes.

Methods

In a prospective British occupational cohort, subject to 5 yearly clinical examinations, we examined ethnic differences in trajectories of fasting plasma glucose (FPG), 2 h post-load plasma glucose (2hPG), fasting serum insulin (FSI), 2 h post-load serum insulin (2hSI), HOMA of insulin sensitivity (HOMA2-S) and secretion (HOMA2-B), and the Gutt insulin sensitivity index (ISI0,120) among 120 South Asian and 867 white participants who developed diabetes during follow-up (1991–2013). We fitted cubic mixed-effects models to longitudinal data with adjustment for a wide range of covariates.

Results

Compared with white individuals, South Asians had a faster increase in FPG before diagnosis (slope difference 0.22 mmol/l per decade; 95% CI 0.02, 0.42; p = 0.03) and a higher FPG level at diagnosis (0.27 mmol/l; 95% CI 0.06, 0.48; p = 0.01). They also had higher FSI and 2hSI levels before and at diabetes diagnosis. South Asians had a faster decline and lower HOMA2-S (log e -transformed) at diagnosis compared with white individuals (0.33; 95% CI 0.21, 0.46; p < 0.001). HOMA2-B increased in both ethnic groups until 7 years before diagnosis and then declined; the initial increase was faster in white individuals. ISI0,120 declined steeply in both groups before diagnosis; levels were lower among South Asians before and at diagnosis. There were no ethnic differences in 2hPG trajectories.

Conclusions/interpretation

We observed different trajectories of plasma glucose, insulin sensitivity and secretion prior to diabetes diagnosis in South Asian and white individuals. This might be due to ethnic differences in the natural history of diabetes. South Asian individuals experienced a more rapid decrease in insulin sensitivity and faster increases in FPG compared with white individuals. These findings suggest more marked disturbance in beta cell compensation prior to diabetes diagnosis in South Asian individuals.
Literature
1.
go back to reference The DECODE Study Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696CrossRef The DECODE Study Group (2003) Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26:688–696CrossRef
2.
go back to reference Chamnan P, Simmons RK, Jackson R, Khaw KT, Wareham NJ, Griffin SJ (2011) Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia 54:291–299CrossRefPubMed Chamnan P, Simmons RK, Jackson R, Khaw KT, Wareham NJ, Griffin SJ (2011) Non-diabetic hyperglycaemia and cardiovascular risk: moving beyond categorisation to individual interpretation of absolute risk. Diabetologia 54:291–299CrossRefPubMed
3.
go back to reference Ikehara S, Tabak AG, Akbaraly TN et al (2015) Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study. Diabetologia 58:534–542CrossRefPubMed Ikehara S, Tabak AG, Akbaraly TN et al (2015) Age trajectories of glycaemic traits in non-diabetic South Asian and white individuals: the Whitehall II cohort study. Diabetologia 58:534–542CrossRefPubMed
4.
go back to reference Holman N, Forouhi NG, Goyder E, Wild SH (2011) The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabet Med 28:575–582CrossRefPubMed Holman N, Forouhi NG, Goyder E, Wild SH (2011) The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabet Med 28:575–582CrossRefPubMed
5.
go back to reference Ning F, Qiao Q, Tuomilehto J et al (2010) Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev 26:245–253CrossRefPubMed Ning F, Qiao Q, Tuomilehto J et al (2010) Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev 26:245–253CrossRefPubMed
6.
go back to reference Raji A, Seely EW, Arky RA, Simonson DC (2001) Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86:5366–5371CrossRefPubMed Raji A, Seely EW, Arky RA, Simonson DC (2001) Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 86:5366–5371CrossRefPubMed
7.
go back to reference Tillin T, Hughes AD, Godsland IF et al (2013) Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent revisited (SABRE) cohort. Diabetes Care 36:383–393CrossRefPubMedPubMedCentral Tillin T, Hughes AD, Godsland IF et al (2013) Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent revisited (SABRE) cohort. Diabetes Care 36:383–393CrossRefPubMedPubMedCentral
8.
go back to reference Sattar N, Gill JM (2015) Type 2 diabetes in migrant South Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol 3:1004–1016CrossRefPubMed Sattar N, Gill JM (2015) Type 2 diabetes in migrant South Asians: mechanisms, mitigation, and management. Lancet Diabetes Endocrinol 3:1004–1016CrossRefPubMed
9.
go back to reference Gujral UP, Mohan V, Pradeepa R et al (2016) Ethnic variations in diabetes and prediabetes prevalence and the roles of insulin resistance and beta-cell function: the CARRS and NHANES studies. J Clin Transl Endocrinol 4:19–27CrossRefPubMed Gujral UP, Mohan V, Pradeepa R et al (2016) Ethnic variations in diabetes and prediabetes prevalence and the roles of insulin resistance and beta-cell function: the CARRS and NHANES studies. J Clin Transl Endocrinol 4:19–27CrossRefPubMed
10.
go back to reference Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140CrossRefPubMed Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140CrossRefPubMed
11.
go back to reference Bhopal RS (2013) A four-stage model explaining the higher risk of type 2 diabetes mellitus in South Asians compared with European populations. Diabet Med 30:35–42CrossRefPubMed Bhopal RS (2013) A four-stage model explaining the higher risk of type 2 diabetes mellitus in South Asians compared with European populations. Diabet Med 30:35–42CrossRefPubMed
12.
go back to reference DeFronzo RA (2009) Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–795CrossRefPubMedPubMedCentral DeFronzo RA (2009) Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58:773–795CrossRefPubMedPubMedCentral
13.
14.
go back to reference Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215–2221CrossRefPubMedPubMedCentral Tabak AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimaki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373:2215–2221CrossRefPubMedPubMedCentral
15.
go back to reference Færch K, Witte DR, Tabak AG et al (2013) Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol 1:43–51CrossRefPubMed Færch K, Witte DR, Tabak AG et al (2013) Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol 1:43–51CrossRefPubMed
16.
go back to reference World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. WHO, Geneva World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. WHO, Geneva
17.
go back to reference World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93:299–309CrossRef World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Diabetes Res Clin Pract 93:299–309CrossRef
18.
go back to reference Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495CrossRefPubMed Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27:1487–1495CrossRefPubMed
19.
go back to reference Gutt M, Davis CL, Spitzer SB et al (2000) Validation of the insulin sensitivity index (ISI0,120): comparison with other measures. Diabetes Res Clin Pract 47:177–184CrossRefPubMed Gutt M, Davis CL, Spitzer SB et al (2000) Validation of the insulin sensitivity index (ISI0,120): comparison with other measures. Diabetes Res Clin Pract 47:177–184CrossRefPubMed
20.
go back to reference Kumari M, Head J, Marmot M (2004) Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Int Med 164:1873–1880CrossRef Kumari M, Head J, Marmot M (2004) Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study. Arch Int Med 164:1873–1880CrossRef
21.
go back to reference Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP (2004) Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 53:160–165CrossRefPubMed Ferrannini E, Nannipieri M, Williams K, Gonzales C, Haffner SM, Stern MP (2004) Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 53:160–165CrossRefPubMed
22.
go back to reference Laspa E, Christen A, Efstathiadou Z, Johnston DG, Godsland IF (2007) Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis. Diabet Med 24:1269–1278CrossRefPubMed Laspa E, Christen A, Efstathiadou Z, Johnston DG, Godsland IF (2007) Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis. Diabet Med 24:1269–1278CrossRefPubMed
23.
go back to reference Sattar N, McConnachie A, Ford I et al (2007) Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 56:984–991CrossRefPubMed Sattar N, McConnachie A, Ford I et al (2007) Serial metabolic measurements and conversion to type 2 diabetes in the west of Scotland coronary prevention study: specific elevations in alanine aminotransferase and triglycerides suggest hepatic fat accumulation as a potential contributing factor. Diabetes 56:984–991CrossRefPubMed
24.
go back to reference Hong J, Gu WQ, Zhang YF et al (2007) The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses. Endocrine 31:93–99CrossRefPubMed Hong J, Gu WQ, Zhang YF et al (2007) The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses. Endocrine 31:93–99CrossRefPubMed
25.
go back to reference Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA (2006) Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074–1079CrossRefPubMed Xiang AH, Wang C, Peters RK, Trigo E, Kjos SL, Buchanan TA (2006) Coordinate changes in plasma glucose and pancreatic beta-cell function in Latino women at high risk for type 2 diabetes. Diabetes 55:1074–1079CrossRefPubMed
26.
go back to reference Mason CC, Hanson RL, Knowler WC (2007) Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes 56:2054–2061CrossRefPubMed Mason CC, Hanson RL, Knowler WC (2007) Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes 56:2054–2061CrossRefPubMed
27.
go back to reference Goff LM, Griffin BA, Lovegrove JA et al (2013) Ethnic differences in beta-cell function, dietary intake and expression of the metabolic syndrome among UK adults of South Asian, black African-Caribbean and white-European origin at high risk of metabolic syndrome. Diab Vasc Dis Res 10:315–323CrossRefPubMed Goff LM, Griffin BA, Lovegrove JA et al (2013) Ethnic differences in beta-cell function, dietary intake and expression of the metabolic syndrome among UK adults of South Asian, black African-Caribbean and white-European origin at high risk of metabolic syndrome. Diab Vasc Dis Res 10:315–323CrossRefPubMed
28.
go back to reference McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382–386CrossRefPubMed McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382–386CrossRefPubMed
29.
go back to reference Abdul-Ghani MA, Matsuda M, DeFronzo RA (2008) Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. Diabet Med 25:1289–1294PubMed Abdul-Ghani MA, Matsuda M, DeFronzo RA (2008) Strong association between insulin resistance in liver and skeletal muscle in non-diabetic subjects. Diabet Med 25:1289–1294PubMed
30.
go back to reference Mari A, Ahren B, Pacini G (2005) Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 8:529–533CrossRefPubMed Mari A, Ahren B, Pacini G (2005) Assessment of insulin secretion in relation to insulin resistance. Curr Opin Clin Nutr Metab Care 8:529–533CrossRefPubMed
31.
32.
go back to reference Stringhini S, Tabak AG, Akbaraly TN et al (2012) Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ 345:e5452CrossRefPubMedPubMedCentral Stringhini S, Tabak AG, Akbaraly TN et al (2012) Contribution of modifiable risk factors to social inequalities in type 2 diabetes: prospective Whitehall II cohort study. BMJ 345:e5452CrossRefPubMedPubMedCentral
Metadata
Title
Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study
Authors
Adam Hulman
Rebecca K. Simmons
Eric J. Brunner
Daniel R. Witte
Kristine Færch
Dorte Vistisen
Satoyo Ikehara
Mika Kivimaki
Adam G. Tabák
Publication date
01-07-2017
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 7/2017
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-017-4275-6

Other articles of this Issue 7/2017

Diabetologia 7/2017 Go to the issue

Up front

Up front

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine